Analysts expect that National Health Investors, Inc. (NYSE:NHI) will report sales of $81.88 million for the current fiscal quarter, according to Zacks. Three analysts have made estimates for National Health Investors’ earnings. The lowest sales estimate is $79.93 million and the highest is $84.82 million. National Health Investors posted sales of $82.19 million in the same quarter last year, which would indicate a negative year-over-year growth rate of 0.4%. The company is expected to announce its next quarterly earnings report on Wednesday, February 17th.
According to Zacks, analysts expect that National Health Investors will report full-year sales of $332.58 million for the current fiscal year, with estimates ranging from $328.68 million to $336.57 million. For the next year, analysts forecast that the company will report sales of $336.70 million, with estimates ranging from $329.10 million to $342.89 million. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that follow National Health Investors.
National Health Investors (NYSE:NHI) last posted its quarterly earnings results on Monday, November 9th. The real estate investment trust reported $0.95 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.43 by ($0.48). The company had revenue of $84.30 million during the quarter, compared to analyst estimates of $82.87 million. National Health Investors had a return on equity of 12.74% and a net margin of 57.44%. The company’s revenue was up 3.2% compared to the same quarter last year. During the same period last year, the company posted $1.42 earnings per share.
Several equities analysts have commented on the stock. Zacks Investment Research raised shares of National Health Investors from a “sell” rating to a “hold” rating in a research report on Thursday. Stifel Nicolaus reissued a “hold” rating and set a $63.00 target price on shares of National Health Investors in a research report on Tuesday, September 1st. Finally, ValuEngine downgraded shares of National Health Investors from a “hold” rating to a “sell” rating in a research report on Thursday, October 1st. Two analysts have rated the stock with a sell rating, seven have given a hold rating and one has issued a buy rating to the company’s stock. National Health Investors has an average rating of “Hold” and a consensus price target of $65.88.
Very rarely do you get an opportunity to get in at the ground level at a new company without having to do anything but own one share of the original company.
National Health Investors stock opened at $65.54 on Friday. The company has a debt-to-equity ratio of 1.03, a current ratio of 13.20 and a quick ratio of 13.20. The company has a market capitalization of $2.93 billion, a price-to-earnings ratio of 15.31 and a beta of 0.79. National Health Investors has a one year low of $31.37 and a one year high of $91.12. The company’s fifty day moving average price is $60.14 and its two-hundred day moving average price is $59.88.
The business also recently announced a quarterly dividend, which was paid on Friday, November 6th. Investors of record on Wednesday, September 30th were issued a dividend of $1.102 per share. This represents a $4.41 annualized dividend and a dividend yield of 6.73%. The ex-dividend date was Tuesday, September 29th. National Health Investors’s payout ratio is 80.18%.
In related news, Director Robert G. Adams bought 1,000 shares of National Health Investors stock in a transaction that occurred on Tuesday, November 17th. The stock was acquired at an average price of $66.45 per share, with a total value of $66,450.00. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 5.74% of the company’s stock.
Several hedge funds have recently made changes to their positions in NHI. Marshall Wace North America L.P. bought a new stake in National Health Investors in the 1st quarter valued at about $31,000. Amundi Pioneer Asset Management Inc. boosted its holdings in National Health Investors by 2.5% in the 1st quarter. Amundi Pioneer Asset Management Inc. now owns 79,619 shares of the real estate investment trust’s stock valued at $6,254,000 after purchasing an additional 1,960 shares during the period. Envestnet Asset Management Inc. boosted its holdings in National Health Investors by 6.9% in the 2nd quarter. Envestnet Asset Management Inc. now owns 7,178 shares of the real estate investment trust’s stock valued at $436,000 after purchasing an additional 462 shares during the period. CWM LLC boosted its holdings in National Health Investors by 28.2% in the 2nd quarter. CWM LLC now owns 16,434 shares of the real estate investment trust’s stock valued at $998,000 after purchasing an additional 3,615 shares during the period. Finally, Janney Montgomery Scott LLC boosted its holdings in National Health Investors by 5.1% in the 2nd quarter. Janney Montgomery Scott LLC now owns 28,997 shares of the real estate investment trust’s stock valued at $1,761,000 after purchasing an additional 1,405 shares during the period. 68.52% of the stock is owned by institutional investors and hedge funds.
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI’s portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
As part of our national response to the Covid-19 pandemic, many Americans considered it their patriotic, if not moral, duty to support the restaurant industry. And while many consumers were intensely focused on their small, local restaurants, the national chains were still open for business during this time.
And the reality is that the national chains are going to be the most adaptable to whatever pace of economic recovery we see. Hopes for a “V” shaped recovery have pretty much gone out the window. The new model suggests a stair-step recovery may be the best-case scenario.
The worst case scenario for the restaurant industry will be one where different regions of the country are subject to rolling lockdowns. In a business with notoriously low margins, an open/close, open/close recovery would be disastrous.
It’s one reason why I’m not sure I would be diving into restaurant stocks right now. But the same was being said of airline stocks and cruise line stocks. And sure enough, discount investors have been trying to invest in these stocks.
But as all 50 states have now re-opened in some fashion, it’s not unlikely that restaurant stocks are drawing attention from investors. We’ve put together this presentation that highlights seven restaurant stocks that you should consider looking at if you want to dive into this sector.